Literature DB >> 21192992

Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus.

Brenda F Canine1, Yuhua Wang, Wenyun Ouyang, Arash Hatefi.   

Abstract

One of the major limitations to effective siRNA delivery is the lack of a siRNA-specific delivery system. Currently, the same delivery systems that are used for plasmid DNA (pDNA) delivery to the cell nucleus are used for siRNA delivery to the cytoplasm. To fill this gap, the objective of this study was to design a biopolymer that can be programmed via its amino acid sequence to deliver siRNA specifically to cytoplasm. For pDNA delivery, a nuclear localization signal (NLS) was added to the biopolymer structure to facilitate active translocation of the genetic material towards nucleus. The biopolymers were complexed with pEGFP and GFP-siRNA and used to transfect SKOV-3 (HER2+) cells. The intracellular trafficking of the nanoparticles was also monitored in real-time and live cells. The results demonstrated that the biopolymer with NLS is a suitable carrier for pDNA delivery but not siRNA delivery. Conversely, the biopolymer without NLS was suitable for siRNA delivery to the cytoplasm but not pDNA to the cell nucleus. The potential use of the designed biopolymer for combination therapy of cancer cells with gene (thymidine kinase) and siRNA (BCL2) was also examined in SKOV-3 cancer cells. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192992      PMCID: PMC3081961          DOI: 10.1016/j.jconrel.2010.12.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

1.  Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells.

Authors:  Sriramchandra S Mangipudi; Brenda F Canine; Yuhua Wang; Arash Hatefi
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

Review 2.  Advances with the use of bio-inspired vectors towards creation of artificial viruses.

Authors:  Helen O McCarthy; Yuhua Wang; Sriramchandra S Mangipudi; Arash Hatefi
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 3.  Development of recombinant cationic polymers for gene therapy research.

Authors:  Brenda F Canine; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2010-04-14       Impact factor: 15.470

4.  Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Authors:  Olga B Garbuzenko; Maha Saad; Seema Betigeri; Min Zhang; Alexandre A Vetcher; Viatcheslav A Soldatenkov; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

5.  Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.

Authors:  Brenda F Canine; Yuhua Wang; Arash Hatefi
Journal:  J Control Release       Date:  2009-04-18       Impact factor: 9.776

6.  Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.

Authors:  Yang Wang; Maha Saad; Refika I Pakunlu; Jayant J Khandare; Olga B Garbuzenko; Alexandre A Vetcher; Viatcheslav A Soldatenkov; Vitaly P Pozharov; Tamara Minko
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

Review 7.  Regulated cell death pathways: new twists in modulation of BCL2 family function.

Authors:  Nidhish Sasi; Misun Hwang; Jerry Jaboin; Ildiko Csiki; Bo Lu
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

Review 8.  The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.

Authors:  Bryan R Meade; Steven F Dowdy
Journal:  Discov Med       Date:  2009-12       Impact factor: 2.970

9.  A designer biomimetic vector with a chimeric architecture for targeted gene transfer.

Authors:  Yuhua Wang; Sriramchandra Sastry Mangipudi; Brenda F Canine; Arash Hatefi
Journal:  J Control Release       Date:  2009-03-18       Impact factor: 9.776

Review 10.  Knocking down barriers: advances in siRNA delivery.

Authors:  Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

View more
  7 in total

1.  Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.

Authors:  Arash Hatefi; Zahra Karjoo; Alireza Nomani
Journal:  Biomacromolecules       Date:  2017-08-24       Impact factor: 6.988

Review 2.  Controlled release from recombinant polymers.

Authors:  Robert Price; Azadeh Poursaid; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 3.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Authors:  Nishant S Gandhi; Rakesh K Tekade; Mahavir B Chougule
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

4.  Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like Peptides.

Authors:  Faranak S Nouri; Xing Wang; Xuguang Chen; Arash Hatefi
Journal:  Pharm Res       Date:  2015-03-31       Impact factor: 4.200

Review 5.  Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Faranak S Nouri; Arash Hatefi
Journal:  Biomaterials       Date:  2017-10-20       Impact factor: 12.479

6.  Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.

Authors:  Yan Li; Ruiyuan Liu; Yuanjie Shi; Zhenzhong Zhang; Xin Zhang
Journal:  Theranostics       Date:  2015-02-27       Impact factor: 11.556

7.  Together is Better: mRNA Co-Encapsulation in Lipoplexes is Required to Obtain Ratiometric Co-Delivery and Protein Expression on the Single Cell Level.

Authors:  Heyang Zhang; Jeroen Bussmann; Florian H Huhnke; Joke Devoldere; An-Katrien Minnaert; Wim Jiskoot; Friedhelm Serwane; Joachim Spatz; Magnus Röding; Stefaan C De Smedt; Kevin Braeckmans; Katrien Remaut
Journal:  Adv Sci (Weinh)       Date:  2021-12-16       Impact factor: 17.521

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.